A detailed history of Ever Source Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 9,699 shares of ABBV stock, worth $1.7 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
9,699
Previous 8,662 11.97%
Holding current value
$1.7 Million
Previous $1.49 Million 28.96%
% of portfolio
0.13%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $169,902 - $206,705
1,037 Added 11.97%
9,699 $1.92 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $287,445 - $335,671
1,857 Added 27.29%
8,662 $1.49 Million
Q1 2024

Jun 11, 2024

BUY
$159.82 - $182.1 $310,530 - $353,820
1,943 Added 39.96%
6,805 $1.24 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $556,867 - $627,163
-4,047 Reduced 45.43%
4,862 $753,000
Q3 2023

Nov 03, 2023

SELL
$133.59 - $154.65 $87,501 - $101,295
-655 Reduced 6.85%
8,909 $1.33 Million
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $406,143 - $505,418
3,065 Added 47.16%
9,564 $1.29 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $16,774 - $19,318
-116 Reduced 1.75%
6,499 $1.04 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $196,400 - $235,535
1,420 Added 27.33%
6,615 $1.07 Million
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $63,078 - $72,347
-470 Reduced 8.3%
5,195 $698,000
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $58,075 - $73,833
-422 Reduced 6.93%
5,665 $868,000
Q1 2022

May 25, 2022

BUY
$131.98 - $163.75 $439,097 - $544,796
3,327 Added 120.54%
6,087 $987,000
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $296,506 - $375,166
2,760 New
2,760 $374,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.